High-sensitivity BRAF mutation analysis: BRAF V600E is acquired early during tumor development but is heterogeneously distributed in a subset of papillary thyroid carcinomas.
about
Selective use of sorafenib in the treatment of thyroid cancerSignificance of the BRAF mRNA Expression Level in Papillary Thyroid Carcinoma: An Analysis of The Cancer Genome Atlas Data.The percentage of Epidermal Growth Factor Receptor (EGFR)-mutated neoplastic cells correlates to response to tyrosine kinase inhibitors in lung adenocarcinoma.Evaluation of molecular diagnostic approaches for the detection of BRAF p.V600E mutations in papillary thyroid cancer: Clinical implications.BRAFV600E mutation in papillary thyroid microcarcinoma: a meta-analysisBRAF Testing in Multifocal Papillary Thyroid Carcinoma.Real-Time PCR Cycle Threshold Values for the BRAFV600E Mutation in Papillary Thyroid Microcarcinoma May Be Associated With Central Lymph Node Metastasis: A Retrospective StudyVE1 immunohistochemical detection of the BRAF V600E mutation in thyroid carcinoma: a review of its usefulness and limitations.Current Advances in Thyroid Cancer Management. Are We Ready for the Epidemic Rise of Diagnoses?Non-canonical IDH1 and IDH2 mutations: a clonal and relevant event in an Italian cohort of gliomas classified according to the 2016 World Health Organization (WHO) criteria.A combination of immunohistochemistry and molecular approaches improves highly sensitive detection of BRAF mutations in papillary thyroid cancer.Clinically significant sub-clonality for common drivers can be detected in 26% of KRAS/EGFR mutated lung adenocarcinomas.Detection of BRAF mutation in Chinese tumor patients using a highly sensitive antibody immunohistochemistry assay.Synchronous and metachronous thyroid cancer in relation to Langerhans cell histiocytosis; involvement of V600E BRAF-mutation?Heterogeneity of driver genes and therapeutic implications in colorectal cancer.Molecular pathology of thyroid tumours of follicular cells: a review of genetic alterations and their clinicopathological relevance.Benign thyroid nodules with RAS mutation grow faster.Thyroid cancers of follicular origin in a genomic light: in-depth overview of common and unique molecular marker candidates
P2860
Q26752891-B6AC90E4-8870-463E-8CEF-9C56E7D0C2B6Q31114420-5360DC33-83AB-4EFF-B960-A03BF0F52DDCQ33693948-FD0282BB-3E84-46FC-834A-891BDBE06E88Q33821945-2F0CCB63-9074-4A0C-9BD5-962B9C7C862BQ35543644-625B8F50-9500-417A-84C9-53335EFEEA1EQ36095556-3A7FF637-7561-4914-87E3-CE3DAD017718Q36196527-D2503057-1173-4C02-9E65-7036E191AC2DQ38426776-D2F3BF00-9B8B-4EDF-92E1-4087F576FD26Q38614394-D8A03D37-DA25-4CA9-9AEA-B0D4EB5BB655Q38658533-6BE96A94-A2C8-44BB-99A2-8C5506EEB846Q40619094-1062F006-4127-4692-8DAB-C3519A5E844AQ41233667-42B53853-360B-48F9-A70D-51B4D1CBBAA2Q41857360-F3482D6D-DE76-4E39-A918-4B1B22BD8A48Q43167956-05D97C0C-58C7-4D35-86AE-B3D3B446D990Q43549198-7ACDB66D-EFB9-4636-9A50-6489E66A095CQ47295202-4EBD28CA-B689-48BB-8DA6-8B303A41311AQ51286115-3F293E80-CA18-4F88-9B9A-D5BE5C4C4249Q58796314-655E1BB8-A77A-42DB-8F76-820D437273FE
P2860
High-sensitivity BRAF mutation analysis: BRAF V600E is acquired early during tumor development but is heterogeneously distributed in a subset of papillary thyroid carcinomas.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
High-sensitivity BRAF mutation ...... papillary thyroid carcinomas.
@en
High-sensitivity BRAF mutation ...... papillary thyroid carcinomas.
@nl
type
label
High-sensitivity BRAF mutation ...... papillary thyroid carcinomas.
@en
High-sensitivity BRAF mutation ...... papillary thyroid carcinomas.
@nl
prefLabel
High-sensitivity BRAF mutation ...... papillary thyroid carcinomas.
@en
High-sensitivity BRAF mutation ...... papillary thyroid carcinomas.
@nl
P2093
P50
P356
P1476
High-sensitivity BRAF mutation ...... f papillary thyroid carcinomas
@en
P2093
Gian Piero Casadei
Moira Ragazzi
Nadia Cremonini
Valentina Cesari
P304
P356
10.1210/JC.2013-4389
P407
P50
P577
2014-04-29T00:00:00Z